Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
January 15, 2021
Are You Ready for 2021 EAEU Regulatory Changes?
Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).
For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.
If you want to find out more information about EAEU registration rules, please contact us at info@inpharmatis.com.
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024
Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024
Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024
Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024
Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024
Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024
Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024